- MOQ2 Bottle(s)
- Supply TypeManufacturer, Exporter, Supplier
- Preferred Buyer Location All over the world
Palbociclib (codenamed PD-0332991, trade name Ibrance) is a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. BRANCE is for postmenopausal women with ER+/HER2- metastatic breast cancer who have not received prior hormone therapy for their metastatic disease.
Member Since 8 Years
Nature of Business Supplier
For Buyer 
For Seller 
Help 
California